Skip to main content
SpringerLink
Log in
Book cover

Drugs Affecting Lipid Metabolism pp 339–342Cite as

HDL as a Risk Factor for Coronary Heart Disease: An Update on the Helsinki Heart Study

  • Chapter

  • 87 Accesses

Part of the book series: Medical Science Symposia Series ((MSSS,volume 2))

Abstract

Since the original observations (1,2) four decades ago that low level of serum high density lipoprotein cholesterol (HDL cholesterol) has an adverse effect on coronary heart disease (CHD) occurence, longitudinal and cross-sectional studies have provided substantial confirmation (3,4). In the Helsinki Heart Study (HHS) we employed the placebo grouplacebo group to explore HDL cholesterol/CHD relationships (5,6). This short report derives from subgroup analyses of the significance of low HDL cholesterol.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barr DP, Russ EM, Eder HA. Am — Med 1951; 11: 480–485.

    Article  CAS  Google Scholar 

  2. Nikkila E. Scand — Clin Lab Invest 1953; 5: suppl 8.

    Google Scholar 

  3. Miller GJ, Miller NE. Lancet 1975; 1: 16–19.

    Article  PubMed  CAS  Google Scholar 

  4. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. Atherosclerosis 1988; 8: 207–211.

    CAS  Google Scholar 

  5. Manninen V, Huttunen JK, Tenkanen L, Heinonen OP, et al. In: Miller NE, ed. High Density Lipoproteins and Atherosclerosis II. Amsterdam: Elsevier, 1989; 35–42.

    Google Scholar 

  6. Frick MH, Manninen V, Huttunen JK, Heinonen OP, et al. Drugs 1990; 40: Suppl. 1: 7–12.

    Article  PubMed  Google Scholar 

  7. Manttari M, Elo O, Frick MH, Haapa K, et. al. Eur Heart — 1987; 8: Suppl. 1: 1–29.

    Article  PubMed  Google Scholar 

  8. Frick MH, Elo O, Haapa K, Heinonen OP, et al. — Engl — Med 1987; 317: 1237–1245.

    Article  CAS  Google Scholar 

  9. Manninen V, Elo O, Frick MH, Haapa K, et al. JAMA 1988; 260: 641–651.

    Article  PubMed  CAS  Google Scholar 

  10. Cox DR, Oakes D. In: Monographs on Statistics and Applied Propability. London: Chapman & Hall Ltd, 1984.

    Google Scholar 

  11. Manninen V, Tenkanen L, Koskinen P, Huttunen JK, et al. Circulation 1992; 85: 37–45.

    Article  PubMed  CAS  Google Scholar 

  12. National Cholesterol Education Program. National Heart, Lung, and Blood Institute publication No (NIH) 1988; 88-2925.

    Google Scholar 

Download references

Authors
  1. M. Mänttäri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Manninen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Istituto di Scienze Farmacologiche, Università di Milano, Via Balzaretti 9, I-20133, Milano, Italy

    A. L. Catapano  & Rodolfo Paoletti (Direttore) &  (Direttore)

  2. Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA

    A. M. Gotto Jr. (Chairman) (Chairman)

  3. Department of Medicine, The Methodist Hospital, 6565 Fannin M.S. A601, Houston, TX, 77030-2797, USA

    Louis C. Smith (Professor of Experimental Medicine) (Professor of Experimental Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Mänttäri, M., Manninen, V. (1993). HDL as a Risk Factor for Coronary Heart Disease: An Update on the Helsinki Heart Study. In: Catapano, A.L., Gotto, A.M., Smith, L.C., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism. Medical Science Symposia Series, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1703-6_41

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1703-6_41

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4746-3

  • Online ISBN: 978-94-011-1703-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation